Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Clinical trial NCT05803785 · RECRUITING

Trial details

NCT number: NCT05803785
Sponsor: Benobio Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2025-07-01
Primary completion: 2026-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.